Overall survival analyses show that the expression of BUB1, CDK1, MET, PAK1, PRKCI, RIPK2, NEK2, FGFR1, NEK9 were significantly correlated with the prognosis of PC patients (Table 1). Here, BUB1 is linked to pachyonychia congenita.